Department of Medical Microbiology and Parasitology, University of Lagos, Lagos, Nigeria.
Pathog Glob Health. 2020 Mar;114(2):55-63. doi: 10.1080/20477724.2020.1731667. Epub 2020 Feb 26.
With the advent of CRISPR (clustered regularly interspaced short palindromic repeat)-based gene drive, present genetic research in schistosomiasis vector control envisages the breeding and release of transgenic schistosome-resistant (TSR) snail vectors to curb the spread of the disease. Although this approach is still in its infancy, studies focussing on production of genetically modified (GM) mosquitoes (including gene-drive mosquitoes) are well advanced and set the pace for other transgenic vector research. Unfortunately, as with other GM mosquitoes, open field release of gene-drive mosquitoes is currently challenged in part by some concerns such as gene drive failure and increased transmission potential for other mosquito-borne diseases among others, which might have adverse effects on human well-being. Therefore, not only should we learn from the GM mosquito protocols, frameworks and guidelines but also appraise the applicability of its current hurdles to other transgenic vector systems, such as the TSR snail approach. Placing these issues in a coherent comparative perspective, I argue that although the use of TSR snails may face similar technical, democratic and diplomatic challenges, some of the concerns over gene-drive mosquitoes may not apply to gene-drive snails, proposing a theory that community consent will be no harder and possibly easier to obtain for TSR snails than the experience with GM mosquitoes. In the future, these observations may help public health practitioners and policy makers in effective communication with communities on issues regarding the use of TSR snails to interrupt schistosomiasis transmission, especially in sub-Saharan Africa.
随着基于 CRISPR(成簇规律间隔短回文重复序列)的基因驱动技术的出现,目前针对血吸虫病传播控制的遗传研究设想培育和释放转基因抗血吸虫病(TSR)螺类传播媒介,以遏制疾病的传播。尽管这种方法仍处于起步阶段,但关于基因改造(GM)蚊子(包括基因驱动蚊子)的研究已经取得了很大进展,为其他转基因媒介研究奠定了基础。不幸的是,与其他 GM 蚊子一样,基因驱动蚊子的野外释放目前在一定程度上面临着一些问题的挑战,例如基因驱动失败和其他蚊媒疾病传播潜力增加等,这些问题可能对人类福祉产生不利影响。因此,我们不仅应该借鉴 GM 蚊子的协议、框架和准则,还应该评估其当前障碍对其他转基因媒介系统(如 TSR 螺类方法)的适用性。从连贯的比较角度来看待这些问题,我认为,尽管 TSR 螺类的使用可能面临类似的技术、民主和外交挑战,但基因驱动蚊子的一些担忧可能不适用于基因驱动螺类,提出了一种理论,即社区同意对于 TSR 螺类来说将不会比 GM 蚊子更难获得,甚至可能更容易获得。在未来,这些观察结果可能有助于公共卫生从业者和政策制定者就 TSR 螺类用于中断血吸虫病传播的问题与社区进行有效的沟通,特别是在撒哈拉以南非洲地区。